Abstracts tagged "anticoagulation and vasculitis"

Abstract Number: 2750 • 2014 ACR/ARHP Annual Meeting
Effects of Anticoagulant Treatment on the Incidence of New Vascular Events in Patients with Behcet’s Disease with Vascular Involvement
Fatma Alibaz-Oner¹, Aslı Karadeniz², Sema Yilmaz³, Ayse Balkarli⁴, Gezmis Kimyon⁵, Ayten Yazici⁶, Muhammed Cinar⁷, Sedat Yilmaz⁷, Fatih Yildiz⁸, Sule Yasar Bilge⁹, Emre Bilgin¹⁰, Belkıs Nihan Şeniz¹¹, Ahmet Omma¹², Gozde Yildirim Cetin¹³, Yonca Cagatay¹⁴, Mehmet Sayarlioglu¹⁵, Yavuz Pehlivan¹⁶, Umut Kalyoncu¹⁷, Omer Karadag¹⁰, Timucin Kasifoglu⁹, Eren Erken⁸, Salih Pay⁷, Ayse Cefle⁶, Bunyamin Kisacik¹⁸, Ahmet Mesut Onat¹⁹, Veli Cobankara²⁰ and Haner Direskeneli¹, ¹Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ²Internal Medicine, Marmara University, School of Medicine, Istanbul, Turkey, ³Department of Rheumatology, Selcuk University School of Medicine, Konya, Turkey, ⁴Department of Rheumatology, Pamukkale University School of Medicine, Denizli, Turkey, ⁵Department of Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁶Department of Rheumatology, Kocaeli University, Kocaeli, Turkey, ⁷Rheumatology, Gulhane Military Medical Academy, Ankara, Turkey, ⁸Rheumatology, Cukurova University, School of Medicine, Adana, Turkey, ⁹Rheumatology, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey, ¹⁰Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ¹¹Rheumatology, Uludağ University, School of Medicine, Bursa, Turkey, ¹²Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ¹³Rheumatology, Kahramanmaras University School of Medicine, Kahramanmaras, Turkey, ¹⁴Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, ¹⁵Rheumatology, Ondokuz Mayis University School of Medicine, Samsun, Turkey, ¹⁶Rheumatology, Uludag University, School of Medicine, Bursa, Turkey, ¹⁷PsAID taskforce, EULAR, Zurich, Switzerland, ¹⁸Rheumatology, Gaziantep University, School of Medicine, Gaziantep, Turkey, ¹⁹Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ²⁰Rheumatology, Pamukkale University, School of Medicine, Denizli, Turkey
Background/Purpose: Vascular involvement (VI) is one of the major causes of mortality and morbidity in Behcet's Disease (BD). There are no controlled studies for the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].